Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...

Innate Pharma S.A. (($FR:IPH)) has held its Q4 earnings call. Read on for the main highlights of the call. Innate Pharma’s recent earnings call ...

influencing processes like cell differentiation, apoptosis, and metabolism. Dysregulated miRNAs are implicated in cancers, ...

Equities researchers at Zacks Small Cap issued their Q1 2025 earnings per share estimates for Soligenix in a research report ...

Maternal influenza vaccination significantly reduces adverse outcomes, including maternal mortality, prematurity, and low birth weight. It also decreases influenza-associated hospitalisations and ...

Fruits and plant extracts contain bioactive compounds that can help treat or prevent diseases. To characterize and understand their mechanism of action, researchers from universities and research ...